64 related articles for article (PubMed ID: 35552451)
21. Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway.
Yan F; Liu R; Zhuang X; Li R; Shi H; Gao X
J Cardiovasc Transl Res; 2021 Apr; 14(2):355-364. PubMed ID: 32671648
[TBL] [Abstract][Full Text] [Related]
22. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
Wang DY; Li N; Cui YL
Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
[TBL] [Abstract][Full Text] [Related]
23. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
Liang G; Meng W; Huang X; Zhu W; Yin C; Wang C; Fassan M; Yu Y; Kudo M; Xiao S; Zhao C; Zou P; Wang Y; Li X; Croce CM; Cui R
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4347-4357. PubMed ID: 32041891
[TBL] [Abstract][Full Text] [Related]
24. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
25. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
26. A long noncoding RNA binding to QKI-5 regulates germ cell apoptosis via p38 MAPK signaling pathway.
Li K; Zhong S; Luo Y; Zou D; Li M; Li Y; Lu Y; Miao S; Wang L; Song W
Cell Death Dis; 2019 Sep; 10(10):699. PubMed ID: 31541077
[TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNA in the Pathogenesis of Cancers.
Chi Y; Wang D; Wang J; Yu W; Yang J
Cells; 2019 Sep; 8(9):. PubMed ID: 31480503
[TBL] [Abstract][Full Text] [Related]
28. Expression analysis of circulating plasma long noncoding RNAs in colorectal cancer: The relevance of lncRNAs ATB and CCAT1 as potential clinical hallmarks.
Abedini P; Fattahi A; Agah S; Talebi A; Beygi AH; Amini SM; Mirzaei A; Akbari A
J Cell Physiol; 2019 Dec; 234(12):22028-22033. PubMed ID: 31093977
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
Yang C; Pan Y; Deng SP
BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
[TBL] [Abstract][Full Text] [Related]
30. YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma.
Han J; Meng J; Chen S; Wang X; Yin S; Zhang Q; Liu H; Qin R; Li Z; Zhong W; Zhang C; Zhang H; Tang Y; Lin T; Gao W; Zhang X; Yang L; Liu Y; Zhou HG; Sun T; Yang C
Cancer Res; 2019 Apr; 79(7):1451-1464. PubMed ID: 30760518
[TBL] [Abstract][Full Text] [Related]
31. Pivotal prognostic and diagnostic role of the long non‑coding RNA colon cancer‑associated transcript 1 expression in human cancer (Review).
Wang N; Yu Y; Xu B; Zhang M; Li Q; Miao L
Mol Med Rep; 2019 Feb; 19(2):771-782. PubMed ID: 30535444
[TBL] [Abstract][Full Text] [Related]
32. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
33. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
Jiang Y; Jiang YY; Xie JJ; Mayakonda A; Hazawa M; Chen L; Xiao JF; Li CQ; Huang ML; Ding LW; Sun QY; Xu L; Kanojia D; Jeitany M; Deng JW; Liao LD; Soukiasian HJ; Berman BP; Hao JJ; Xu LY; Li EM; Wang MR; Bi XG; Lin DC; Koeffler HP
Nat Commun; 2018 Sep; 9(1):3619. PubMed ID: 30190462
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.
Huang H; Chen J; Ding CM; Jin X; Jia ZM; Peng J
J Cell Mol Med; 2018 Jun; 22(6):3238-3245. PubMed ID: 29602203
[TBL] [Abstract][Full Text] [Related]
35. Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.
Gupta SK; Garg A; Bär C; Chatterjee S; Foinquinos A; Milting H; Streckfuß-Bömeke K; Fiedler J; Thum T
Circ Res; 2018 Jan; 122(2):246-254. PubMed ID: 29133306
[TBL] [Abstract][Full Text] [Related]
36. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
[TBL] [Abstract][Full Text] [Related]
37. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNAs in Cancer and Therapeutic Potential.
Renganathan A; Felley-Bosco E
Adv Exp Med Biol; 2017; 1008():199-222. PubMed ID: 28815541
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
